Phase 3 Trials
The latest news about Phase 3 Trials: headlines, AI summaries and the full story from every source.
- Definium Therapeutics Reports Positive Phase 3 Clinical Results and Strong Cash Position for Q3 2026
- J&J's Long-Term Data Shows High Remission Rates for Crohn’s Disease Patients on Tremfya
- Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing
- Eli Lilly Reports Improved Weight Loss with Combination Obesity Treatment in Mid-Stage Trial
- BioNTech's Lung Cancer Drug Shows Promising Survival Results in Phase 3 Trial
- Moderna Stock Surges 127% on Positive Cancer Vaccine Trial Results
- Intellia Therapeutics Shares Rise on Positive Lonvo-Z Trial Results
- Revolution Medicines Reports Positive Phase 3 Trial Results for Pancreatic Cancer Drug
- 4D Molecular Therapeutics Reports Q1 Results, Advances Clinical Programs
- Pfizer Begins Phase 3 Trial for New Pneumococcal Vaccine in Infants
- Nektar Therapeutics Q1 2026 Earnings Call Summary
- Truist Reaffirms Buy Rating on Eli Lilly Following Positive Trial Results for Foundayo
- Third Rock Ventures Sells $17.2 Million in Rapport Therapeutics Shares Amid 230% Stock Surge
- Sagimet Biosciences Announces U.S. Phase 3 Trials for Acne Treatment Denifanstat